The purpose of this study was to perform a prospective assessment of the long-term safety of statins in patients with prediabetes/T2DM and NASH. The authors concluded that statin therapy is safe in patients with prediabetes/T2DM and biopsy-proven NASH.
Bril F, Sanchez P P, Lomonaco R, Orsak B, Hecht J, Tio F & Cusi K. (2017). Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post-hoc Analysis of a Randomized Trial. J Clin Endocrine Metab